The Simcyp® population-based ADME simulator

Masoud Jamei, Steve Marciniak, Kairui Feng, Adrian Barnett, Geoffrey Tucker, Amin Rostami-Hodjegan

    Research output: Contribution to journalArticlepeer-review

    Abstract

    The Simcyp® population-based absorption, distribution, metabolism and excretion simulator is a platform and database for 'bottom-up' mechanistic modelling and simulation of the processes of oral absorption, tissue distribution, metabolism and excretion of drugs and drug candidates in healthy and disease populations. It combines experimental data generated routinely during preclinical drug discovery and development from in vitro enzyme and cellular systems and relevant physicochemical attributes of compound and dosage form with demographic, physiological and genetic information on different patient populations. The mechanistic approach implemented in the Simcyp Simulator allows simulation of complex absorption, distribution, metabolism and excretion outcomes, particularly those involving multiple drug interactions, parent drug and metabolite profiles and time- and dose-dependent phenomena such as auto-induction and auto-inhibition. This review describes the framework and organisation of the simulator and how it combines the different categories of information. © 2009 Informa UK Ltd. All rights reserved.
    Original languageEnglish
    Pages (from-to)211-223
    Number of pages12
    JournalExpert Opinion on Drug Metabolism and Toxicology
    Volume5
    Issue number2
    DOIs
    Publication statusPublished - Feb 2009

    Keywords

    • ADME
    • In vitro-in vivo extrapolation
    • Modelling and simulation
    • Physiologically-based pharmacokinetic models
    • Population-based pharmacokinetic modelling
    • Simcyp®

    Fingerprint

    Dive into the research topics of 'The Simcyp® population-based ADME simulator'. Together they form a unique fingerprint.

    Cite this